Testicular cancer is unusual among cancers: it most often strikes young men in their 20s and 30s, and survival rates are excellent—over 95% at five years. But a good prognosis doesn’t mean the psychological impact disappears once treatment ends. Two independent Norwegian studies following long-term survivors found a striking pattern: anxiety remains significantly elevated for years after treatment, while depression, perhaps surprisingly, does not. Understanding this distinction—and why younger survivors carry the heaviest burden—can help survivors and the people who support them recognize when extra support is needed.
Anxiety, Not Depression, Is the Hidden Long-Term Burden
A 2005 study of 1,408 long-term testicular cancer survivors in Norway, treated 10 to 25 years earlier, used the Hospital Anxiety and Depression Scale (HADS) to compare survivors against age-adjusted population norms. The results were striking: 19.2% of survivors met criteria for an anxiety disorder (95% CI 17.2–21.3%), compared to 13.5% in the general population (95% CI 13.1–13.9%)—a statistically significant difference (P<.001) representing a 49% increased relative risk (RR=1.49, 95% CI 1.31–1.69). Depression told a different story: 9.7% of survivors met criteria for depression (95% CI 8.1–11.2%), compared to 10.1% in the general population (95% CI 9.5–10.5%)—not a significant difference (P=.56, RR=0.96, 95% CI 0.81–1.14). In other words, long after treatment ends, anxiety persists as a measurable excess burden, while depression settles back to ordinary population levels.
Coping Strategies for Testicular Cancer Survivors
- Recognize that lingering anxiety years after treatment is a documented pattern, not a personal failing. Long-term studies show anxiety disorder rates remain elevated even a decade or more after successful treatment, so persistent worry doesn’t mean something is wrong with how you’re coping—it’s a recognized part of survivorship.
- Don’t assume depression is the main thing to watch for. Research consistently finds depression rates in testicular cancer survivors are no higher than—and sometimes slightly lower than—the general population, so anxiety and relapse fear deserve more attention than mood alone.
- Name specific sources of anxiety, like relapse fear, sexual problems, or economic strain. A multivariate analysis of this cohort found anxiety was specifically linked to relapse anxiety, sexual problems, economic strain, and alcohol use—being concrete about which of these fits you helps target the right support.
- If you were treated at a young age, know you may carry a higher burden. Across these studies, the youngest survivors consistently showed the most extreme emotional scores, both the highest anxiety and the most variable depression, making early-diagnosed survivors a particularly important group to check in on.
- Ask your care team about chronic fatigue, not just mood. A companion study found chronic fatigue affected 16% of long-term survivors (compared to 10% of the general population), and fatigue, anxiety, and depression often reinforce each other.
- Seek support even if your care team calls you ‘cured.’ Because distress can persist many years into survivorship, long after oncology follow-up ends, it’s worth proactively seeking mental health support rather than waiting for a doctor to ask.
Fatigue and the Youngest Survivors Carry the Heaviest Weight
A related 2003 study of 791 testicular cancer survivors compared them to Hodgkin’s disease survivors and the general population using the Fatigue Questionnaire and HADS. Chronic fatigue affected 16% of testicular cancer survivors, compared to 24% of Hodgkin’s disease survivors and 10% of the general population—with the gap to the general population being especially pronounced in survivors under 30 (P<.01). Mean anxiety scores in testicular cancer survivors were significantly above general-population levels, similar to Hodgkin’s disease survivors, while mean depression scores were actually below the general population. Notably, the youngest survivors showed the most extreme scores on both fronts—the highest anxiety and the most variable depression—leading the researchers to conclude that anxiety is a larger problem than depression in these survivors, particularly among the youngest.
When to Seek Additional Support
If you’re a testicular cancer survivor experiencing ongoing worry, relapse fear, sexual difficulties, or fatigue that doesn’t improve with rest, these are recognized long-term effects—not signs that you should simply be grateful and move on. Reach out to a doctor, oncology counselor, or therapist if anxiety is interfering with daily life, relationships, or sleep, especially if you were diagnosed at a young age or are dealing with economic or alcohol-related stress alongside it. Support groups specifically for testicular cancer survivors can also help normalize these experiences, since the condition’s relatively young patient population means survivors often feel isolated from typical cancer-support spaces.
Quick Tips for Managing Testicular Cancer-Related Distress
- Track anxiety separately from mood. Because anxiety and depression follow different patterns in testicular cancer survivors, monitoring them separately helps you and your care team notice what’s actually happening.
- Mention relapse fear directly at follow-up appointments. Relapse anxiety is one of the specific documented correlates of long-term distress, so naming it gives your care team something concrete to address.
- If you were diagnosed young, seek survivor peer support. Younger survivors show the most extreme emotional outcomes in research, making peer connection with others who were diagnosed early especially valuable.
- Don’t dismiss fatigue as ‘just getting older.’ Chronic fatigue is measurably more common in testicular cancer survivors than in the general population, and it’s worth discussing with your care team rather than normalizing.